References
Lamontagne F, Meade MO, Hebert PC, Asfar P, Lauzier F, Seely AJ, Day AG, Mehta S, Muscedere J, Bagshaw SM, Ferguson ND, Cook DJ, Kanji S, Turgeon AF, Herridge MS, Subramanian S, Lacroix J, Adhikari NK, Scales DC, Fox-Robichaud A, Skrobik Y, Whitlock RP, Green RS, Koo KK, Tanguay T, Magder S, Heyland DK, Canadian Critical Care Trials Group (2016) Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42:542–550. doi:10.1007/s00134-016-4237-3
Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M (1996) Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med 22:17–25
Kavanagh BP, Meyer LJ (2005) Normalizing physiological variables in acute illness: five reasons for caution. Intensive Care Med 31:1161–1167
Abid O, Akca S, Haji M, Vincent JL (2000) Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med 28:947–949
Dunser MW, Takala J, Brunauer A, Bakker J (2013) Re-thinking resuscitation: leaving blood pressure cosmetics behind and moving forward to permissive hypotension and a tissue perfusion-based approach. Crit Care 17:326
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Bakker, J., Takala, J. Vasopressor therapy: not like antibiotics!. Intensive Care Med 42, 1195–1196 (2016). https://doi.org/10.1007/s00134-016-4335-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-016-4335-2